Literature DB >> 18181147

Suppression of human tumor cell proliferation by Smurf2-induced senescence.

Hong Zhang1, Yuchin Teng, Yahui Kong, Paul E Kowalski, Stanley N Cohen.   

Abstract

The limitation of proliferative potential in human somatic cells imposed by replicative senescence has been proposed as a mechanism of tumor suppression. The E3 ubiquitin ligase Smurf2 is up-regulated during replicative senescence in response to telomere shortening, and induces senescence when expressed adventitiously in early passage or telomerase-immortalized human fibroblasts. To investigate the generality of Smurf2's control of cell proliferation, we have studied the effects of Smurf2 up-regulation on cell proliferation in early passage human mammary epithelial cells which normally do not show elevated expression of Smurf2 during senescence, and in 16 human cancer cell lines derived from both sarcomas and carcinomas. Here we report that Smurf2 up-regulation induced senescence in a wide variety of human cell types, including highly neoplastic cell lines. Consistent with our previous findings, the ability of Smurf2 to arrest cell proliferation did not require its ubiquitin ligase activity. Furthermore, expression of the cyclin-dependent kinase inhibitor p21 was increased in tumor cells undergoing Smurf2-induced senescence, and such increase occurred independently of the transactivation function of p53. Our results, which reveal a previously unsuspected tumor suppression function for Smurf2-induced senescence, suggest that modulation of Smurf2 action may be a useful strategy for inhibition of cancer cell growth. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181147     DOI: 10.1002/jcp.21337

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Smurf2-mediated ubiquitination and degradation of Id1 regulates p16 expression during senescence.

Authors:  Yahui Kong; Hang Cui; Hong Zhang
Journal:  Aging Cell       Date:  2011-10-07       Impact factor: 9.304

2.  "Smurf"-ing tumors on the chromatin through RNF20.

Authors:  Wen-Wei Tsai
Journal:  Protein Cell       Date:  2012-02       Impact factor: 14.870

3.  Downregulation of Smurf2 ubiquitin ligase in pancreatic cancer cells reversed TGF-β-induced tumor formation.

Authors:  Bo Wu; Bomin Guo; Jie Kang; Xianzhao Deng; Youben Fan; Xiaoping Zhang; Kaixing Ai
Journal:  Tumour Biol       Date:  2016-10-11

Review 4.  Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?

Authors:  Corinne Abbadie; Olivier Pluquet; Albin Pourtier
Journal:  Cell Mol Life Sci       Date:  2017-07-13       Impact factor: 9.261

5.  Smurf2 regulates the senescence response and suppresses tumorigenesis in mice.

Authors:  Charusheila Ramkumar; Yahui Kong; Hang Cui; Suyang Hao; Stephen N Jones; Rachel M Gerstein; Hong Zhang
Journal:  Cancer Res       Date:  2012-05-02       Impact factor: 12.701

6.  Notch3 functions as a tumor suppressor by controlling cellular senescence.

Authors:  Hang Cui; Yahui Kong; Mei Xu; Hong Zhang
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

7.  Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells.

Authors:  Xiangchun Wang; Chaoyang Jin; Yi Tang; Liu-Ya Tang; Ying E Zhang
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

8.  An anti-cancer Smurf.

Authors:  Keji Zhao; Yun-Bo Shi
Journal:  Cell Biosci       Date:  2012-03-19       Impact factor: 7.133

9.  Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1.

Authors:  Charusheila Ramkumar; Hang Cui; Yahui Kong; Stephen N Jones; Rachel M Gerstein; Hong Zhang
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.

Authors:  K R Manda; P Tripathi; A C Hsi; J Ning; M B Ruzinova; H Liapis; M Bailey; H Zhang; C A Maher; P A Humphrey; G L Andriole; L Ding; Z You; F Chen
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.